)
Devangshu Datta, an internationally rated chess and bridge player, is a seasoned writer and columnist with extensive experience covering diverse topics such as finance, technology, science, and sports. Known for his analytical approach and clear writing style, Datta has contributed to several leading publications, including Business Standard, The Economic Times, The Telegraph, and Outlook. He also serves on the editorial board of Business Standard.
Devangshu Datta, an internationally rated chess and bridge player, is a seasoned writer and columnist with extensive experience covering diverse topics such as finance, technology, science, and sports. Known for his analytical approach and clear writing style, Datta has contributed to several leading publications, including Business Standard, The Economic Times, The Telegraph, and Outlook. He also serves on the editorial board of Business Standard.
And the business possibilities they present are immense - even unfathomable
It would make sense for the law to be rewritten to allow recreational and medical use. The drug could then be taxed
Festive season hasn't seen strong pick-up, margin pressures continue
A reversal in stress in microfinance and housing loan segments is crucial to improve sentiment
Analysts, however, remain positive with target prices indicating 13-25% upside on expectations of strong growth in FY22 earnings
PSB stocks have outperformed private rivals, and momentum looks strong
Demand-supply scenario is favourable and should keep prices elevated
Auto, energy and realty have been the big gainers since September 1
Space-related activities have enormous potential for accelerating growth across the broader economy
Strong deal wins are likely to keep revenue growth elevated
But given an optimistic market and a good monsoon, an upside is more likely
The 2021 Nobel for Physiology (or Medicine) went to David Julius and Ardem Patapoutian for their "discoveries of receptors for temperature and touch"
But with a trailing PE of 90 the stock is now a momentum trade
People use FB and its subsidiaries for many reasons, ranging from casual interactions with friends, to generating income in various ways
This vaccine has been in development for 30 long years
Capacity expansion, high operational efficiency, focus on renewables and reasonable valuation are triggers
The share price of Muthoot Fin has risen 31% over last year, but Manappuram underperformed with 9% return
Lower rates to aid loan demand for financiers who can offset discounts over the long tenure
Share prices have risen in past fortnight on hopes of recovery in biz
ONGC, Oil India stand to gain, but downstream players may feel the heat